J2KBIO Co., Ltd.

₩7,670As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:420570Healthcare
Country South Korea
PE (Fwd) •••
TSR 3Y CAGR (26.32%)
Div yield 3.26%
ROE 16.91%
Biological Products, Except Diagnostic Substances
Beta (5Y) 0.51
PE TTM 7.715
TSR TTM (8.75%)
Mkt cap ₩44.85B
ROIC 20.23%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩8,023
4.60%
(8.12%)
Hold 4|9|4|8|9
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
96.82
96.72
107.84
111.73
14.74%
18.69%
23.36%
20.49%
Revenue₩B
5.275
5.576
5.844
6.017
1.06%
4.34%
10.27%
15.24%
Peers (US$33.07M)
Cap (US$)
PE
33.02M
—
30.91M
—
Capital
TTM
5Y
10Y
Leveragex
1.319
(0.371)
(0.371)
EBIT/Intx
1.827
0.091
0.107
Own earn%
(40.02)
37.78
26.89
Sh yield%
22.80
62.14
60.04
Owners
Insiders/Inst%
10.38
77.65
Short interest%
4.46
SBC / revenue%
2.93
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
13–16
$1 testx
—
Incr. ROIC%
−2